EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of Gut Microbiota in Breast Cancer and Drug Resistance

Sathiyapriya Viswanathan iD, Sheetal Parida, Bhuvana Teja Lingipilli, Ramalingam Krishnan, Devendra Rao Podipireddy, Nethaji Muniraj iD

Pathogens · 16.03.2023 · 12 (3) · 468

DOI: 10.3390/pathogens12030468 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 16.03.2023. Verfasst von Sathiyapriya Viswanathan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, ACS Medical College and Hospital, Chennai 600007, Tamil Nadu, India. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most common malignancy in women worldwide. The cause of cancer is multifactorial. An early diagnosis and the appropriate treatment of cancer can improve the chances of survival. Recent studies have shown that breast cancer is influenced by the microbiota. Different microbial signatures have been identified in the breast microbiota, which have different patterns depending on the stage and biological subgroups. The human digestive system contains approximately 100 trillion bacteria. The gut microbiota is an emerging field of research that is associated with specific biological processes in many diseases, including cardiovascular disease, obesity, diabetes, brain disease, rheumatoid arthritis, and cancer. In this review article, we discuss the impact of the microbiota on breast cancer, with a primary focus on the gut microbiota’s regulation of the breast cancer microenvironment. Ultimately, updates on how immunotherapy can affect the breast cancer-based microbiome and further clinical trials on the breast and microbiome axis may be an important piece of the puzzle in better predicting breast cancer risk and prognosis.

Schlagwörter

Stichwörter der Autor:innen

biomarker and immunotherapybreast cancercancer therapeuticsdrug resistancemicrobiome

Autor:innen und Institutionen

  • Department of Biochemistry, ACS Medical College and Hospital, Chennai 600007, Tamil Nadu, India.
  • Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
  • Gandhi Institute of Technology and Management (GITAM), Deemed University, Visakhapatnam 530045, Andhra Pradesh, India.
  • Department of Biochemistry, Narayana Medical College, Nellore 524003, Andhra Pradesh, India.
  • Rangaraya Medical College, Dr. YSR University of Health Sciences, Kakinada 533001, Andhra Pradesh, India.
  • Center for Cancer and Immunology Research, Children's National Hospital, 111, Michigan Ave NW, Washington, DC 20010, USA.

ORCID-Profile: Sathiyapriya Viswanathan, Nethaji Muniraj

Zitieren

APA

Viswanathan, S., Parida, S., Lingipilli, B. T., Krishnan, R., Podipireddy, D. R., & Muniraj, N. (2023). Role of Gut Microbiota in Breast Cancer and Drug Resistance. Pathogens, 12(3), 468. https://doi.org/10.3390/pathogens12030468

Vancouver

Viswanathan S, Parida S, Lingipilli BT, Krishnan R, Podipireddy DR, Muniraj N. Role of Gut Microbiota in Breast Cancer and Drug Resistance. Pathogens. 2023;12(3):468. doi:10.3390/pathogens12030468

BibTeX
@article{Viswanathan2023,
  author = {Viswanathan, Sathiyapriya and Parida, Sheetal and Lingipilli, Bhuvana Teja and Krishnan, Ramalingam and Podipireddy, Devendra Rao and Muniraj, Nethaji},
  title = {Role of Gut Microbiota in Breast Cancer and Drug Resistance},
  journal = {Pathogens},
  year = {2023},
  volume = {12},
  number = {3},
  pages = {468},
  doi = {10.3390/pathogens12030468}
}
Kostenlos starten →